RCKT

Rocket Pharmaceuticals, Inc.$3.44-0.05 (-1.43%)

Prev Close$3.49·MCap$384.1M·P/E—·Vol2.38M·Yield—

▲

Buys (12M)

$68.5K

▼

Sells (12M)

$338.9K

◆

Net Activity

Net Seller

$270.4K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Rocket Pharmaceuticals, Inc. (RCKT) has been dominated by selling, with 2 insider purchases totaling $68.5K and 23 insider sales totaling $338.9K. The most recent insider transaction was by Militello John (officer: See Remarks), who sold $3.9K worth of shares on Feb 20, 2026. Rocket Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $384.1M.

RCKT Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 20, 2026	Militello John	officer: See Remarks	Sell	1,157	$3.34	$3.9K	91,019
Feb 20, 2026	Shah Gaurav	officer: CEO	Sell	5,990	$3.34	$20.0K	1,046,055
Feb 20, 2026	Wilson Martin	officer: General Counsel	Sell	1,376	$3.34	$4.6K	682,000
Feb 18, 2026	Militello John	officer: See Remarks	Sell	3,726	$3.31	$12.3K	92,176
Feb 18, 2026	Shah Gaurav	officer: CEO	Sell	12,279	$3.31	$40.7K	1,052,045
Feb 18, 2026	Wilson Martin	officer: General Counsel	Sell	12,253	$3.31	$40.6K	683,376
Jan 2, 2026	Bjork Elisabeth	Director	Buy	10,000	$3.44	$34.4K	0
Nov 18, 2025	Militello John	See Remarks	Sell	1,086	$2.98	$3.2K	0
Nov 18, 2025	Schwartz Jonathan David	See Remarks	Sell	2,545	$2.98	$7.6K	0
Nov 18, 2025	Shah Gaurav	CEO	Sell	6,276	$2.98	$18.7K	0
Nov 18, 2025	Wilson Martin	General Counsel	Sell	1,646	$2.98	$4.9K	0
Oct 14, 2025	Militello John	See Remarks	Sell	28,918	$3.96	$114.6K	0
Aug 27, 2025	Bjork Elisabeth	Director	Buy	10,000	$3.41	$34.1K	0
Aug 18, 2025	Militello John	See Remarks	Sell	1,060	$3.04	$3.2K	0
Aug 18, 2025	Schwartz Jonathan David	See Remarks	Sell	2,485	$3.04	$7.6K	0
Aug 18, 2025	Shah Gaurav	CEO	Sell	2,234	$3.05	$6.8K	0
Aug 18, 2025	Wilson Martin	General Counsel	Sell	1,592	$3.04	$4.8K	0
Jul 3, 2025	Ondrey Aaron	Chief Financial Officer	Sell	1,477	$2.88	$4.3K	0
May 20, 2025	Militello John	See Remarks	Sell	357	$6.45	$2.3K	0
May 20, 2025	Patel Kinnari	See Remarks	Sell	767	$6.45	$4.9K	0
May 20, 2025	Schwartz Jonathan David	See Remarks	Sell	801	$6.45	$5.2K	0
May 20, 2025	Shah Gaurav	CEO	Sell	2,253	$6.45	$14.5K	0
May 20, 2025	Wilson Martin	General Counsel	Sell	587	$6.45	$3.8K	0
May 16, 2025	Militello John	See Remarks	Sell	655	$6.53	$4.3K	0
May 16, 2025	Wilson Martin	General Counsel	Sell	946	$6.53	$6.2K	0
Apr 22, 2025	Militello John	See Remarks	Sell	718	$7.16	$5.1K	0
Apr 10, 2025	Shah Gaurav	CEO	Buy	20,000	$5.08	$101.6K	0
Apr 9, 2025	Patel Kinnari	See Remarks	Buy	21,099	$4.70	$99.2K	0
Apr 4, 2025	Ondrey Aaron	Chief Financial Officer	Sell	7,489	$5.29	$39.6K	0
May 17, 2024	Schwartz Jonathan David	See Remarks	Sell	15,093	$14.84	$224.0K	0
Apr 1, 2022	Schwartz Jonathan David	See Remarks	Sell	45,000	$16.41	$738.7K	213,967
Feb 8, 2022	Shah Gaurav	CEO	Buy	22,000	$17.34	$381.5K	517,639
Jun 21, 2021	Makker Gotham		Sell	35,085	$46.85	$1.64M	1,296,801
May 13, 2021	RTW INVESTMENTS, LP	Director	Sell	725,000	$40.03	$29.02M0.7% OS	15,460,119

RCKT Insider Buying Activity

The following table shows recent insider purchases of Rocket Pharmaceuticals, Inc. (RCKT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jan 2, 2026	Bjork Elisabeth	Director	Buy	10,000	$3.44	$34.4K	0
Aug 27, 2025	Bjork Elisabeth	Director	Buy	10,000	$3.41	$34.1K	0
Apr 10, 2025	Shah Gaurav	CEO	Buy	20,000	$5.08	$101.6K	0
Apr 9, 2025	Patel Kinnari	See Remarks	Buy	21,099	$4.70	$99.2K	0
Feb 8, 2022	Shah Gaurav	CEO	Buy	22,000	$17.34	$381.5K	517,639

RCKT Insider Selling Activity

The following table shows recent insider sales of Rocket Pharmaceuticals, Inc. (RCKT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 20, 2026	Militello John	officer: See Remarks	Sell	1,157	$3.34	$3.9K	91,019
Feb 20, 2026	Shah Gaurav	officer: CEO	Sell	5,990	$3.34	$20.0K	1,046,055
Feb 20, 2026	Wilson Martin	officer: General Counsel	Sell	1,376	$3.34	$4.6K	682,000
Feb 18, 2026	Militello John	officer: See Remarks	Sell	3,726	$3.31	$12.3K	92,176
Feb 18, 2026	Shah Gaurav	officer: CEO	Sell	12,279	$3.31	$40.7K	1,052,045
Feb 18, 2026	Wilson Martin	officer: General Counsel	Sell	12,253	$3.31	$40.6K	683,376
Nov 18, 2025	Militello John	See Remarks	Sell	1,086	$2.98	$3.2K	0
Nov 18, 2025	Schwartz Jonathan David	See Remarks	Sell	2,545	$2.98	$7.6K	0
Nov 18, 2025	Shah Gaurav	CEO	Sell	6,276	$2.98	$18.7K	0
Nov 18, 2025	Wilson Martin	General Counsel	Sell	1,646	$2.98	$4.9K	0
Oct 14, 2025	Militello John	See Remarks	Sell	28,918	$3.96	$114.6K	0
Aug 18, 2025	Militello John	See Remarks	Sell	1,060	$3.04	$3.2K	0
Aug 18, 2025	Schwartz Jonathan David	See Remarks	Sell	2,485	$3.04	$7.6K	0
Aug 18, 2025	Shah Gaurav	CEO	Sell	2,234	$3.05	$6.8K	0
Aug 18, 2025	Wilson Martin	General Counsel	Sell	1,592	$3.04	$4.8K	0
Jul 3, 2025	Ondrey Aaron	Chief Financial Officer	Sell	1,477	$2.88	$4.3K	0
May 20, 2025	Militello John	See Remarks	Sell	357	$6.45	$2.3K	0
May 20, 2025	Patel Kinnari	See Remarks	Sell	767	$6.45	$4.9K	0
May 20, 2025	Schwartz Jonathan David	See Remarks	Sell	801	$6.45	$5.2K	0
May 20, 2025	Shah Gaurav	CEO	Sell	2,253	$6.45	$14.5K	0
May 20, 2025	Wilson Martin	General Counsel	Sell	587	$6.45	$3.8K	0
May 16, 2025	Militello John	See Remarks	Sell	655	$6.53	$4.3K	0
May 16, 2025	Wilson Martin	General Counsel	Sell	946	$6.53	$6.2K	0
Apr 22, 2025	Militello John	See Remarks	Sell	718	$7.16	$5.1K	0
Apr 4, 2025	Ondrey Aaron	Chief Financial Officer	Sell	7,489	$5.29	$39.6K	0
May 17, 2024	Schwartz Jonathan David	See Remarks	Sell	15,093	$14.84	$224.0K	0
Apr 1, 2022	Schwartz Jonathan David	See Remarks	Sell	45,000	$16.41	$738.7K	213,967
Jun 21, 2021	Makker Gotham		Sell	35,085	$46.85	$1.64M	1,296,801
May 13, 2021	RTW INVESTMENTS, LP	Director	Sell	725,000	$40.03	$29.02M0.7% OS	15,460,119